基因组编辑
从长凳到床边
清脆的
生物
工程伦理学
Cas9
知识库
计算生物学
生物技术
数据科学
遗传学
计算机科学
基因
万维网
工程类
医学
医学物理学
作者
Elizabeth M. Porto,Alexis C. Komor
出处
期刊:PLOS Biology
[Public Library of Science]
日期:2023-04-12
卷期号:21 (4): e3002071-e3002071
被引量:52
标识
DOI:10.1371/journal.pbio.3002071
摘要
With the advent of recombinant DNA technology in the 1970s, the idea of using gene therapies to treat human genetic diseases captured the interest and imagination of scientists around the world. Years later, enabled largely by the development of CRISPR-based genome editing tools, the field has exploded, with academic labs, startup biotechnology companies, and large pharmaceutical corporations working in concert to develop life-changing therapeutics. In this Essay, we highlight base editing technologies and their development from bench to bedside. Base editing, first reported in 2016, is capable of installing C•G to T•A and A•T to G•C point mutations, while largely circumventing some of the pitfalls of traditional CRISPR/Cas9 gene editing. Despite their youth, these technologies have been widely used by both academic labs and therapeutics-based companies. Here, we provide an overview of the mechanics of base editing and its use in clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI